Phosphorus trichloride → 2-Benzhydryloxycarbonyl-3-{2-[(2-methyl-1,3,4-thiadiazol-5-yl)-thio]-prop-1-en-1-yl}-7-[2-methoxyimino-2-(2-tritylaminothiazol-4-yl)-acetamido]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene

HRID 463581ノート

反応式

HRID 463581 の反応式
[CH:1]([O:14][C:15]([C:17]1[N:18]2[CH:21]([S:22](=O)[CH2:23][C:24]=1[CH:25]=[C:26]([S:28][C:29]1[S:33][C:32]([CH3:34])=[N:31][N:30]=1)[CH3:27])[CH:20]([NH:36][C:37](=[O:67])[C:38](=[N:64][O:65][CH3:66])[C:39]1[N:40]=[C:41]([NH:44][C:45]([C:58]3[CH:63]=[CH:62][CH:61]=[CH:60][CH:59]=3)([C:52]3[CH:57]=[CH:56][CH:55]=[CH:54][CH:53]=3)[C:46]3[CH:51]=[CH:50][CH:49]=[CH:48][CH:47]=3)[S:42][CH:43]=1)[C:19]2=[O:68])=[O:16])([C:8]1[CH:13]=[CH:12][CH:11]=[CH:10][CH:9]=1)[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1.CN(C)C(=O)C.P(Cl)(Cl)Cl.C(=O)(O)[O-].[Na+]>C(Cl)Cl.O.C(OCC)(=O)C>[CH:1]([O:14][C:15]([C:17]1[N:18]2[CH:21]([S:22][CH2:23][C:24]=1[CH:25]=[C:26]([S:28][C:29]1[S:33][C:32]([CH3:34])=[N:31][N:30]=1)[CH3:27])[CH:20]([NH:36][C:37](=[O:67])[C:38](=[N:64][O:65][CH3:66])[C:39]1[N:40]=[C:41]([NH:44][C:45]([C:46]3[CH:51]=[CH:50][CH:49]=[CH:48][CH:47]=3)([C:52]3[CH:53]=[CH:54][CH:55]=[CH:56][CH:57]=3)[C:58]3[CH:59]=[CH:60][CH:61]=[CH:62][CH:63]=3)[S:42][CH:43]=1)[C:19]2=[O:68])=[O:16])([C:2]1[CH:3]=[CH:4][CH:5]=[CH:6][CH:7]=1)[C:8]1[CH:9]=[CH:10][CH:11]=[CH:12][CH:13]=1

参加物

8

反応物 4

HCID 24387Phosphorus trichlorideHCID 31374DimethylacetamideHCID 516892Sodium BicarbonateHCID 544407692-Benzhydryloxycarbonyl-3-{2-[(2-methyl-1,3,4-thiadiazol-5-yl)-thio]-prop-1-en-1-yl}-7-[2-methoxyimino-2-(2-tritylaminothiazol-4-yl)-acetamido]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-5-oxide

生成物 1

HCID 536585572-Benzhydryloxycarbonyl-3-{2-[(2-methyl-1,3,4-thiadiazol-5-yl)-thio]-prop-1-en-1-yl}-7-[2-methoxyimino-2-(2-tritylaminothiazol-4-yl)-acetamido]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene収率 31.1%

試薬・触媒・溶媒 3

HCID 962Water溶媒HCID 6344Dichloromethane溶媒HCID 8857Ethyl Acetate溶媒

反応条件

温度
-10 °C

実験手順

A solution of the Z form of the syn isomer of 2-benzhydryloxycarbonyl-3-{2-[(2-methyl-1,3,4-thiadiazol-5-yl)-thio]-prop-1-en-1-yl}-7-[2-methoxyimino-2-(2-tritylaminothiazol-4-yl)-acetamido]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-5-oxide (2.52 g) in methylene chloride (40 cc) is cooled to -10° C. N,N-Dimethylacetamide (0.95 cc) and phosphorus trichloride (0.7 g) are added successively. The solution is stirred for 20 minutes at -10° C. and then poured into a saturated aqueous solution of sodium bicarbonate (50 cc). It is diluted with distilled water (200 cc) and extraction is carried out with ethyl acetate (300 cc). The organic phase is dried over sodium sulphate and concentrated to dryness under reduced pressure (20 mm Hg; 2.7 kPa) at 20° C. The residue is chromatographed on a column of Merck silica gel (0.06-0.20) (25 g) (diameter of the column: 2 cm; height: 15 cm). Elution is carried out with a 50/50 (by volume) ethyl acetate/cyclohexane mixture (500 cc), 30 cc fractions being collected. Fractions 4 to 13 are concentrated to dryness under reduced pressure (20 mm Hg; 2.7 kPa) at 20° C. This yields the Z form of the syn isomer of 2-benzhydryloxycarbonyl-3-{2-[(2-methyl-1,3,4-thiadiazol-5-yl)-thio]-prop-1-en-1-yl}-7-[2-methoxyimino-2-(2-tritylaminothiazol-4-yl)-acetamido]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene (0.77 g) in the form of a hard white foam.

後処理

  1. dry with materialThe organic phase is dried over sodium sulphate
  2. concentrationconcentrated to dryness under reduced pressure (20 mm Hg; 2.7 kPa) at 20° C
  3. customThe residue is chromatographed on a column of Merck silica gel (0.06-0.20) (25 g) (diameter of the column
  4. washElution
  5. custombeing collected
  6. concentrationFractions 4 to 13 are concentrated to dryness under reduced pressure (20 mm Hg; 2.7 kPa) at 20° C

出典と根拠

ORDレコード
ord-e2660ce8f61d43fca5b95acb71323d09
出典データセット
uspto-grants-1985_05
特許番号
US04520193

反応ノート

読み込み中…